Stocks to Watch Today, November 28

The stocks to watch today include a mix of major corporate acquisitions, regulatory updates, technology partnerships, and healthcare expansions that are likely to guide market sentiment. As the share market today responds to new deals, leadership changes, block transactions, and operational developments across sectors, investors can expect a data-heavy trading session driven by company-specific actions.

Share Market News – Highlights

• Adani Enterprises acquires majority stake in FSTC
• Wipro signs European transformation deal
• Global Health expands NCR footprint with new Medanta hospital
• Tata Technologies completes Es-Tec acquisition
• Ashoka Buildcon receives temporary bid suspension
• Zydus Lifesciences secures USFDA approval
• Emcure Pharmaceuticals faces GST department inspection
• Bajaj Healthcare appoints new COO
• Rail Vikas Nigam wins new surveillance project
• Large institutional block deals
• New listing and corporate actions

Adani Enterprises: Move Into Flight Simulation Training

Adani Enterprises announced a major expansion into aviation training after its subsidiary, Adani Defence Systems & Technologies Ltd (ADSTL), along with Prime Aero Services LLP, agreed to acquire a 72.8% stake in Flight Simulation Technique Centre (FSTC) for ₹820 crore. Signed on November 27, the transaction positions the conglomerate as a key player in India’s growing pilot training ecosystem.

FSTC is one of India’s largest independent flight simulation and training providers, operating full-flight simulators and training aircraft for commercial pilot licences, recurrent training, and advanced skill development across airlines.

Wipro: Multi-Year Technology Deal in Europe

Wipro disclosed a multi-year strategic agreement with Odido Netherlands B.V. aimed at modernising its IT landscape and enhancing customer experience across enterprise and consumer divisions. This engagement will rely on AI-driven platforms to raise operational efficiency and streamline digital processes.

The deal follows Wipro's broader strategy of deploying self-funded transformation models, wherein productivity savings are reinvested to support continued innovation. The partnership is expected to strengthen Odido’s long-term digital roadmap.

Global Health (Medanta): Large Hospital Launch in Noida

Global Health Ltd, the operator of Medanta hospitals, inaugurated a 550-bed super speciality hospital in Noida’s Sector 50. The new facility expands Medanta’s presence in NCR and western Uttar Pradesh, offering tertiary and quaternary care across more than 25 medical specialities.

The hospital was inaugurated by the Chief Minister of Uttar Pradesh and is positioned to serve a wide catchment across Delhi-NCR, enhancing access to advanced healthcare services in the region.

Tata Technologies: Completes Es-Tec Acquisition

Tata Technologies confirmed the early completion of its €75 million acquisition of Germany-based Es-Tec GmbH and its subsidiaries. The acquisition strengthens the company’s global engineering and R&D capabilities, particularly in automotive product development.

With operations across Europe, the Es-Tec Group supports leading automakers with engineering services, testing, validation, and system integration — areas that align with Tata Technologies’ strategic expansion.

Ashoka Buildcon: Temporary Suspension From NHAI Bids

Ashoka Buildcon reported that the National Highways Authority of India (NHAI) has temporarily restricted the company from participating in ongoing and future bids for one month. The decision follows a show-cause notice related to the collapse of two precast girders on NH-66, which resulted in a fatality.

The company stated it did not compromise public safety and will cooperate with the Expert Committee’s investigation. The suspension will remain until the inquiry concludes or until the one-month period ends, whichever is later.

Zydus Lifesciences: Tentative USFDA Approval

Zydus Lifesciences received tentative approval from the USFDA for Empagliflozin and Linagliptin tablets in 10 mg/5 mg and 25 mg/5 mg strengths. These are generic versions of Glyxambi, used to improve glycaemic control in adults with type 2 diabetes.

The tablets will be manufactured at Zydus’ Special Economic Zone facility in Ahmedabad. The company noted that the approved formulation contributes to the US market for diabetes care therapies.

Emcure Pharmaceuticals: GST Department Inspection

Emcure Pharmaceuticals reported that the Maharashtra State GST Department conducted a search and inspection at its Mumbai offices between November 24 and 26. The company confirmed providing all requested documents and clarifications.

Emcure stated that no official communication has indicated adverse findings and emphasised that the inspection has no material impact on its financial performance or operations.

Bajaj Healthcare: New COO Appointment

Bajaj Healthcare announced that Shreekumar Shankarnarayan Nair has been appointed Chief Operating Officer and Senior Management Personnel effective November 27. With four decades of leadership experience across major Indian pharmaceutical companies, his appointment is expected to strengthen operational oversight.

Rail Vikas Nigam: New Railway Surveillance Project

Rail Vikas Nigam Ltd (RVNL) received a Letter of Acceptance worth ₹9.64 crore from East Coast Railway. The project involves installing, testing, and commissioning an IP-based video surveillance system across rolling stock of the railway zone.

Bombay Dyeing: Planned Maintenance Shutdown

Bombay Dyeing informed exchanges that its Patalganga facility will undergo a scheduled shutdown from November 28 to December 18 for maintenance. The temporary closure is expected to reduce production by approximately 7,500 metric tons.

However, with sufficient reserve stock of polyester staple fibre (PSF), the company expects no disruption in supply commitments.

Excelsoft Technologies: New e-Testing Partnership

Excelsoft Technologies secured a contract from VTCT Skills to implement its digital e-Testing system, involving up to 3 lakh exams per year. The partnership increases the company’s presence in global assessment technology solutions.

Lemon Tree Hotels: Two New Properties

Lemon Tree Hotels announced new agreements for properties in Surat (near the airport) and Haridwar. The expansion aligns with the chain’s strategy to grow its mid-scale and premium hospitality footprint across India.

Bandhan Bank: Plans to Sell NPA Portfolio

Bandhan Bank approved the sale of ₹3,212 crore worth of NPAs and ₹3,719 crore worth of written-off loans via ARC bidding or permitted transferees. The move is part of its balance sheet optimisation strategy, targeting better asset quality visibility.

Bulk Deals and Large Equity Transactions

CarTrade Tech

Smallcap World Fund acquired 14.44 lakh shares (3.03%) worth ₹439.9 crore, while Goldman Sachs reduced its position by selling 10.71 lakh shares for ₹326.18 crore.

Whirlpool of India

Whirlpool Mauritius sold 1.42 crore shares (11.23%) for ₹1,489.6 crore, reducing its holding below 50%. Several institutional investors collectively acquired a 4.4% stake worth nearly ₹582 crore.

Saregama India

Amansa Holdings sold 24.58 lakh shares (1.2% stake) of Saregama for ₹95.04 crore, exiting a sizeable portion of its earlier 2.75% holding.

MTAR Technologies

Promoter Kavitha Reddy Gangapatnam divested 2.45 lakh shares (0.8%) worth ₹60 crore. Mutual funds including Bajaj Finserv MF and Motilal Oswal MF absorbed the stake.

Listings and Corporate Actions

Sudeep Pharma is set for mainboard listing today. Thyrocare Technologies trades ex-bonus. Unison Metals trades ex-split. Aryavan Enterprise, Meera Industries, and Nile trade ex-dividend.

Overall, the share market today is expected to witness activity across aviation, pharmaceuticals, technology services, engineering, healthcare, and consumer goods, driven primarily by acquisitions, approvals, partnerships, and large institutional transactions.